+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Immunicum AB (IMMU) - Financial and Strategic SWOT Analysis Review

  • ID: 4281635
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell carcinoma, renal cell carcinoma, and gastrointestinal stromal carcinoma. Its other pipeline programs include SUBCUVAX, Ad5PTDf35 - Adenovirusvector and CD70 among others. Immunicum spans its expertise in the development of allogeneic, off-the-shelf cell-based therapies. The company works in partnership with academia, biotech and pharmaceutical companies to develop and commercialize new therapeutics. Immunicum is headquartered in Gothenburg, Sweden.

Immunicum AB Key Recent Developments

Feb 16, 2018: Immunicum Reports Net Loss Of TSEK18,826 In Fourth Quarter Of 2017
Jan 31, 2018: Immunicum Appoints Michaela Gertz As CFO
Jan 31, 2018: Michaela Gertz Joins Immunicum as CFO
Jan 09, 2018: Immunicum ends patient enrolment for Phase II trial of Ilixadencel
Dec 04, 2017: Immunicum Announces Report from the Extraordinary General Meeting on December 4, 2017

This comprehensive SWOT profile of Immunicum AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immunicum AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Immunicum AB - Key Information
  • Immunicum AB - Overview
  • Immunicum AB - Key Employees
  • Immunicum AB - Key Employee Biographies
  • Immunicum AB - Key Operational Heads
  • Immunicum AB - Major Products and Services
  • Immunicum AB - History
  • Immunicum AB - Company Statement
  • Immunicum AB - Locations And Subsidiaries
  • Immunicum AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Immunicum AB - Business Description
  • Immunicum AB - Corporate Strategy
  • Immunicum AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Immunicum AB - Strengths
  • Immunicum AB - Weaknesses
  • Immunicum AB - Opportunities
  • Immunicum AB - Threats
  • Immunicum AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • Immunicum AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Immunicum AB, Key Information
  • Immunicum AB, Key Ratios
  • Immunicum AB, Share Data
  • Immunicum AB, Major Products and Services
  • Immunicum AB, History
  • Immunicum AB, Key Employees
  • Immunicum AB, Key Employee Biographies
  • Immunicum AB, Key Operational Heads
  • Immunicum AB, Other Locations
  • Immunicum AB, Subsidiaries
  • Immunicum AB, Key Manufacturing facilities
  • Immunicum AB, Key Competitors
  • Immunicum AB, SWOT Analysis
  • Immunicum AB, Ratios based on current share price
  • Immunicum AB, Annual Ratios
  • Immunicum AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Immunicum AB, Performance Chart
  • Immunicum AB, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3